v3.25.2
Financial Instruments (Tables)
12 Months Ended
Jun. 29, 2025
Fair Value Disclosures [Abstract]  
Schedule of Cash, Cash Equivalents, Investments, and Other Assets Measured at Fair Value on Recurring Basis
The financial instruments reported within Cash and cash equivalents in the Company’s Consolidated Balance Sheets as of June 29, 2025, and June 30, 2024 consisted of the following:
June 29,
2025
June 30,
2024
(in thousands)
Money market funds (fair value measured on a recurring basis, level 1)$3,151,084 $2,543,462 
Cash1,662,236 1,568,315 
Time deposits1,577,339 1,736,079 
Total$6,390,659 $5,847,856